221 related articles for article (PubMed ID: 37577919)
1. The battle of lipid-based nanocarriers against blood-brain barrier: a critical review.
Abla KK; Mehanna MM
J Drug Target; 2023 Sep; 31(8):832-857. PubMed ID: 37577919
[TBL] [Abstract][Full Text] [Related]
2. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives.
Han H; Li S; Xu M; Zhong Y; Fan W; Xu J; Zhou T; Ji J; Ye J; Yao K
Adv Drug Deliv Rev; 2023 May; 196():114770. PubMed ID: 36894134
[TBL] [Abstract][Full Text] [Related]
3. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
4. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
[TBL] [Abstract][Full Text] [Related]
6. Recent advances on drug delivery nanocarriers for cerebral disorders.
Zhou Z; Sun T; Jiang C
Biomed Mater; 2021 Feb; 16(2):024104. PubMed ID: 33455956
[TBL] [Abstract][Full Text] [Related]
7. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.
Agosti E; Zeppieri M; Antonietti S; Battaglia L; Ius T; Gagliano C; Fontanella MM; Panciani PP
Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543223
[TBL] [Abstract][Full Text] [Related]
8. Lipid Nanocarriers for Enhanced Delivery of Temozolomide to the Brain.
Khosa A; Krishna KV; Dubey SK; Saha RN
Methods Mol Biol; 2020; 2059():285-298. PubMed ID: 31435928
[TBL] [Abstract][Full Text] [Related]
9. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
10. Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Colloids Surf B Biointerfaces; 2023 Jan; 221():112999. PubMed ID: 36368148
[TBL] [Abstract][Full Text] [Related]
11. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
Jain D; Rashid MA; Ahmad FJ
Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
[TBL] [Abstract][Full Text] [Related]
13. Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches.
Aslam M; Javed MN; Deeb HH; Nicola MK; Mirza MA; Alam MS; Akhtar MH; Waziri A
CNS Neurol Disord Drug Targets; 2022; 21(10):952-965. PubMed ID: 34967302
[TBL] [Abstract][Full Text] [Related]
14. Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview.
Song YH; De R; Lee KT
Adv Colloid Interface Sci; 2023 Oct; 320():103008. PubMed ID: 37776736
[TBL] [Abstract][Full Text] [Related]
15. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Patel RJ; Ajazuddin ; Ravichandiran V; Murty US; Alexander A
J Control Release; 2020 May; 321():372-415. PubMed ID: 32061621
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles and blood-brain barrier: the key to central nervous system diseases.
Domínguez A; Suárez-Merino B; Goñi-de-Cerio F
J Nanosci Nanotechnol; 2014 Jan; 14(1):766-79. PubMed ID: 24730296
[TBL] [Abstract][Full Text] [Related]
17. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
18. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery.
Elezaby RS; Gad HA; Metwally AA; Geneidi AS; Awad GA
J Control Release; 2017 Sep; 261():43-61. PubMed ID: 28648865
[TBL] [Abstract][Full Text] [Related]
20. Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood-Brain Barrier Transmitters.
Amiri M; Jafari S; Kurd M; Mohamadpour H; Khayati M; Ghobadinezhad F; Tavallaei O; Derakhshankhah H; Sadegh Malvajerd S; Izadi Z
ACS Chem Neurosci; 2021 Dec; 12(24):4475-4490. PubMed ID: 34841846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
